ROCKVILLE, Md., Oct. 28 /PRNewswire-FirstCall/ -- Vanda Pharmaceuticals Inc. (Vanda) , a biopharmaceutical company focused on the development and commercialization of clinical-stage product candidates for central nervous system disorders, today announced it will release results for the quarter ended September 30, 2009, on Monday, November 2, 2009, before the market opens. A full text copy of the release will be disseminated at that time.
The teleconference dial-in numbers are as follows:
International callers 1-617-786-4501
The conference call will be broadcast simultaneously and archived on the Company’s Web site, www.vandapharma.com. Investors should go to the Web site at least 15 minutes early to register, download, and install any necessary audio software.
ABOUT VANDA PHARMACEUTICALS INC.:
CONTACT: Stephanie R. Irish, Acting Chief Financial Officer, Vanda
Pharmaceuticals Inc., +1-240-599-4500, stephanie.irish@vandapharma.com
Web site: http://www.vandapharma.com/
